MINIMAL BIOMARKERS AND RELATED NEXT-GENERATION SEQUENCING KIT FOR DIAGNOSING ALZHEIMER'S DISEASE FROM INTESTINAL MICROBIOME

摘要

The invention is related to clinically diagnosing Alzheimer's disease or to a support system that aids in diagnosis. The technique of the invention is based on significant clinical findings and determination of certain bacteria genes in the intestinal microbiome that are different from the measurements directed to human protein and miRNA.